Cargando…
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment
Chromosomal translocations are the main etiological factor of hematologic malignancies. These translocations are generally the consequence of aberrant DNA double-strand break (DSB) repair. DSBs arise either exogenously or endogenously in cells and are repaired by major pathways, including non-homolo...
Autores principales: | Valikhani, Mohsen, Rahimian, Elahe, Ahmadi, Seyed Esmaeil, Chegeni, Rouzbeh, Safa, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564991/ https://www.ncbi.nlm.nih.gov/pubmed/34732266 http://dx.doi.org/10.1186/s40164-021-00242-1 |
Ejemplares similares
-
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021) -
Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021) -
Role of mammalian Mre11 in classical and alternative non-homologous end joining
por: Xie, Anyong, et al.
Publicado: (2009) -
WRN regulates pathway choice between classical and alternative non-homologous end joining
por: Shamanna, Raghavendra A., et al.
Publicado: (2016) -
Homology and enzymatic requirements of microhomology-dependent alternative end joining
por: Sharma, S, et al.
Publicado: (2015)